Purpose: To evaluate available options for the management of nephrolithiasis in patients
with autosomal dominant polycystic kidney disease (ADPKD). Materials and Methods: Case …

Abstract Background and Purpose: Autosomal dominant polycystic kidney disease (ADPKD)
manifests with renal and extrarenal abnormalities and is inherited in an autosomal dominant …

PURPOSE:: We evaluate the role of contemporary urological intervention in patients with
nephrolithiasis associated with autosomal dominant polycystic kidney disease. MATERIALS …

Nephrolithiasis is an important manifestation of autosomal dominant polycystic kidney
disease (ADPKD), which occurs in approximately 20% of patients. It should always enter the …

Background and objectives: Nephrolithiasis (LIT) is more prevalent in patients with
autosomal dominant polycystic kidney disease (ADPKD) than in the general population …

OBJECTIVES: To evaluate the role of percutaneous nephrolithotomy in management of the
patients with autosomal dominant polycystic kidney disease and associated nephrolithiasis …

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited systemic disorder.
Renal stones have a high rate of occurrence among patients with ADPKD and are a …

The prevalence of nephrolithiasis is considerably greater in patients with autosomal
dominant polycystic kidney disease (ADPKD) than in the general population. We evaluated …

Objective: To evaluate the efficacy and safety of percutaneous nephrolithotomy (PCNL) in
the treatment of congenital autosomal dominant polycystic kidney disease (ADPKD) with …

Objectives: Nephrolithiasis has been reported in 20-28% of patients, of whom 50% are
symptomatic for stone disease and 20% require definite urologic intervention. The …